13
JHH = 6.13 Hz, Ar), 8.52 (1H, m, Ar), 8.59 (1H, s, Ar). C NMR (100 MHz, CDCl3) δ: 61.0
(t1:1:1, CD, JCD = 22.71 Hz), 125.3, 139.5, 140.6, 144.8, 145.7. HRMS (ESI+): Calculated for
C6H7DNO [M+H]+ 111.0669. Found 111.0663.
4.2.11. 4-Pyridine-[2H]-methanol (27). The title compound was prepared from 13 following
general procedure. An morphous solid. (8.9 mg, 81 %). The product was purified by column
chromatography (SiO2, hexane/EtOAc 7:3) Rf = 0.27. 1H NMR (400 MHz, CDCl3) δ: 2.17 (1H,
bs, OH), 4.94 (1H, s, CHD), 7.67 (2H, d, JHH = 6.54, Ar), 8.53 (2H, d, JHH = 6.13, Ar).
13C NMR (100 MHz, CDCl3) δ: 62.3 (t1:1:1, CD, JCD = 21.9 Hz), 122.4, 146.5, 158.1. HRMS
(TOF MS EI+) Calculated for C6H6DNO 110.0590. Found 110.0592.
4.2.12. Isoquinoline-[2H]-methanol (28). The title compound was prepared from 14 following
general procedure. An amorphous solid. (13.1 mg, 82 %). The product was purified by column
1
chromatography (SiO2, hexane/EtOAc/MeOH 7:3:1) Rf = 0.32. H NMR (400 MHz, CDCl3)
δ: 4.85 (1H, bs, OH), 4.91 (1H, m, CHD), 7.29 (1H, d, JHH = 8.5 Hz, Ar), 7.55 (1H, ddd, JHH
=
8.1 and 6.9 and 1.2 Hz, Ar), 7.68–7.77 (1H, m, Ar), 7.83 (1H, dd, JHH = 8.1 and 1.5 Hz, Ar),
13
8.05–8.10 (1H, m, Ar), 8.15 (1H, d, JHH = 8.5 Hz, Ar). C NMR (100 MHz, CDCl3) δ: 63.9
(t1:1:1, CD, JCD = 21.96), 118.5, 126.5, 127.8, 128.8, 129.2, 130.0, 137.0, 146.8, 159.0. HRMS
(TOF MS EI+): Calculated for C10H8DNO: Calculated 160.0747. Found 160.0754.
4.2.13. (10-[2H]-9,10-Dihydroanthracen-9-yl-10-d)-[2H]-methanol (29). The title compound
was prepared from 15 following general procedure. An orange oil. (16.7 mg, 78 %). The
1
product was purified by column chromatography (SiO2, hexane/EtOAc 7:3) Rf = 0.40. H
NMR (300 MHz, CDCl3) δ: 3.64 (1H, dt, JHH = 7.5 and 1.4 Hz, CHD-OH), 3.89 (1H, bs, Ar-
H-9), 4.10 (1H, d, JHH = 6.8 Hz, Ar-H-10), 7.21–7.28 (4H, m, Ar), 7.28–7.38 (4H, m, Ar). 13C
NMR (75 MHz, CDCl3) δ: 34.9 (td, CDH-10, JCD = 19.85 and 2.12 Hz), 50.1 (C-9), 66.2 (td,
CDH-OH, JCD = 22.20 and 4.60 Hz), 126.5, 127.0, 128.2, 128.6, 136.2, 136.6. HRMS (TOF
MS EI+): Calculated for C15H12D2ONa 235.1068 Found 235.1060.
4.2.14. [(3-hydroxy-[2H]methyl)phenyl]ethanone (30). The title compound was prepared from
16 following general procedure. A yellowih oil. (9.9 mg, 66 %). The product was purified by
column chromatography (SiO2, hexane/EtOAc/MeOH 7:3:1) Rf = 0.37. 1H NMR (300 MHz,
CDCl3) δ: 2.54–2.68 (3H, m, CH3), 4.75 (1H, m, CHD), 7.47 (1H, t, JHH = 7.6 Hz, Ar), 7.55–
13
7.62 (1H, m, Ar), 7.88 (1H, dt, JHH = 7.7 and 1.5 Hz, Ar), 7.93–7.98 (1H, m, Ar). C NMR
(75 MHz, CDCl3) δ: 26.8, 64.6 (t1:1:1, CD, JCD = 21.59 Hz), 126.8, 127.7, 123.0, 131.7, 137.5,
141.4, 198.2. HRMS (TOF MS EI+): Calculated for C9H9DO2 151.0744. Found 151.0745.
4.3. General procedure for very low pressure FLP-assisted tritiation
A 1 mL round bottomed side-arm flask equipped with a magnetic stir bar was mounted onto
the manifold system, evacuated to below 5×10-3 mbar and dried by vacuum-inert sequence.
Carrier-free tritium gas (190 mbar, 2.5 Ci, 93 GBq) stored on the uranium bed was released by
heating to 500 °C into reaction flask. A 0.1M solution of B(C6F5)3 (1 mL, 100 µmol) in toluene,
and 2,2,6,6-tetramethylpiperidine (18 µL, 100 µmol) was drop wise added and vigorously
This article is protected by copyright. All rights reserved.